EVALUATION OF DRY EYE TREATMENT OUTCOMES AND SIDE EFFECTS OF 3% DIQUAFOSOL AFTER 4 WEEKS OF TREATMENT AMONG STUDENTS AT BAC LIEU MEDICAL COLLEGE
Main Article Content
Abstract
Background: Dry eye is a chronic condition caused by tear film instability, leading to discomfort and/or visual impairment, possibly accompanied by ocular surface damage. Objectives: To evaluate the overall treatment outcomes for dry eye and the side effects of 3% Diquafosol. Materials and methods: A cross-sectional descriptive study was conducted on 728 students currently enrolled at Bac Lieu Medical College. Treatment outcomes were assessed using the OSDI scale and tear film stability (FBUT).Results: Diquafosol 3% proved to be a safe treatment option for dry eye, with a 100% cure rate within the first 4 weeks (p<0.001) and minimal side effects (3.7% reported symptoms). Conclusions: Diquafosol 3% is a safe and effective treatment option for dry eye disease.
Article Details
Keywords
Diquafosol 3%, dry eye, FBUT.
References

2. Hội Nhãn khoa Việt Nam (2022), Khuyến nghị trong thực hành lâm sàng Chẩn đoán và điều trị bệnh lý khô mắt tại Việt Nam, Nhà Xuất Bản Y Học.

3. Yokoi Norihiko (2021), TFOD và TFOT Chẩn đoán và điều trị khô mắt dựa vào phim nước mắt, Nhà xuất bản Y học.

4. Aćimović L, Stanojlović S, Kalezić T, Krnjaja BD (2022), "Evaluation of dry eye symptoms and risk factors among medical students in Serbia", Plos one, 17(10), pp. e0275624.

5. Doughty M J, Glavin S (2009), "Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review", Ophthalmic and Physiological Optics, 29(6), pp. 573-583.

6. Eom Y, Kim HM (2021), "Clinical effectiveness of diquafosol ophthalmic solution 3% in Korean patients with dry eye disease: a multicenter prospective observational study", International Journal of Ophthalmology, 14(10), pp. 1518.

7. Tsubota K, Yokoi N, Shimazaki J, Watanabe H, Dogru M, et al (2017), "New perspectives on dry eye definition and diagnosis: a consensus report by the Asia Dry Eye Society", The ocular surface, 15(1), pp. 65-76.

8. Wang W, Sun X, Zhao J, Hao J, Zhao S, et al (2023), "3% diquafosol sodium eye drops in Chinese patients with dry eye: a phase IV study", Frontiers in Medicine, 10, pp. 1089613.

9. Wu D, Chen WQ, Li R, Wang Y (2015), "Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials", Cornea, 34(6), pp. 644-650.
